Assessment of pruritus in atopic dermatitis: validation of the Severity of Pruritus Scale (SPS)
Itch · 2018
DOI: 10.1097/itx.0000000000000013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Itch, 2018. Verfasst von Gil Yosipovitch und 11 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pruritus, or itch, is a central feature of atopic dermatitis (AD) and is often cited as the most bothersome symptom. The Severity of Pruritus Scale (SPS) is a 4-point rating scale adapted from the Atopic Dermatitis Severity Index to provide a measure of pruritus severity within a 24-hour recall period. The objective of this analysis was to assess the qualitative and quantitative validity of the SPS in AD.
Methods
Content validity of the SPS was evaluated qualitatively in US patients with AD. Psychometric properties of the SPS were evaluated using data from 2 phase 3 trials conducted to investigate crisaborole in mild to moderate AD (study AD-301: NCT02118766; study AD-302: NCT02118792).
Results
Fourteen patients were included in the qualitative analysis, considered adequate because of the single-item, single-concept nature of the SPS. Itch was the most prevalent symptom, and the SPS was easily understood and completed in US English (n=9) and US Spanish (n=5). The psychometric analysis used data from 1344 patients. Test-retest reliability analysis identified an intraclass correlation coefficient of 0.54 for a single SPS observation, and at least 0.70 when at least 2 SPS observations were averaged. SPS scores correlated with Investigator’s Static Global Assessment (ISGA) scores, measures of quality of life, and 4 of 5 signs of AD (Pearson correlations, ≥0.40 at day 29). The difference in score between the no disease group/clear (ISGA 0) and the severe disease group (ISGA 4) was 0.80. The clinically important difference was estimated to be 0.20 and the clinically important response was estimated to be at least a 0.19-point reduction from baseline.
Discussion
The SPS is an appropriate tool to assess itch in patients with AD and is a valid and reliable measure of pruritus severity.
Zitieren
APA
Yosipovitch, G., Simpson, E. L., Bushmakin, A. G., Cappelleri, J. C., Luger, T., Ständer, S., Tom, W. L., Benjamin, K., Ports, W. C., Tallman, A. M., Tan, H., & Gerber, R. A. (2018). Assessment of pruritus in atopic dermatitis: validation of the Severity of Pruritus Scale (SPS). Itch. https://doi.org/10.1097/itx.0000000000000013
Vancouver
Yosipovitch G, Simpson EL, Bushmakin AG, Cappelleri JC, Luger T, Ständer S, et al. Assessment of pruritus in atopic dermatitis: validation of the Severity of Pruritus Scale (SPS). Itch. 2018. doi:10.1097/itx.0000000000000013
BibTeX
@article{Yosipovitch2018,
author = {Yosipovitch, Gil and Simpson, Eric L. and Bushmakin, Andrew G. and Cappelleri, Joseph C. and Luger, Thomas and Ständer, Sonja and Tom, Wynnis L. and Benjamin, Katy and Ports, William C. and Tallman, Anna M. and Tan, Huaming and Gerber, Robert A.},
title = {Assessment of pruritus in atopic dermatitis: validation of the Severity of Pruritus Scale (SPS)},
journal = {Itch},
year = {2018},
doi = {10.1097/itx.0000000000000013}
}
EUVIMED